Whereas in RA serum S100A8/A9 has been widely accepted as a powerful serum biomarker to assess disease activity and to predict therapy response [8], its role as a serum biomarker in seronegative arthritis is still under investigation [9–12]. The gene discussed is S100A8; the disease is rheumatoid arthritis.